Financière de Tubize SA (EBR:TUB)

Market Cap	8.71B +75.7%
Revenue (ttm)	n/a
Net Income	93.23M +3.5%
EPS	2.09 +3.5%
Shares Out	44.51M
PE Ratio	93.44
Forward PE	n/a
Dividend	1.08 (0.55%)
Ex-Dividend Date	May 7, 2026

Volume	35,082
Average Volume	24,528
Open	189.80
Previous Close	191.50
Day's Range	189.20 - 195.70
52-Week Range	114.80 - 250.50
Beta	0.37
RSI	35.40
Earnings Date	Mar 21, 2026

About Financière de Tubize

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1928
• Employees: 3
• Stock Exchange: Euronext Brussels
• Ticker Symbol: TUB